Chart 2. Individual results of studies.
| Maternal outcomes | Neonatal outcomes | |||||||
|---|---|---|---|---|---|---|---|---|
| Author | Progression to pre-eclampsia1 | Gestational age at birth (weeks)2 | Cesarean delivery1 | Birth Weight (grams)2 | Admission to neonatal ICU1 | LGA at Birth1 | Occurrence of neonatal hypoglycemia1 | APGAR in the 5th minute3 |
| Ijäs et al. (2010)(15) | -0,01 [-0,11, 0,10] | 0,40 [-0,2, 1,00] | -0,18 [-0,36, -0,01] | -154 (-359,60, 51,60) | 0,07 [-0,08, 0,22] | 0,01 [-0,10, 0,13] | -0,05 [-0,20, 0,10] | 8,9 ± 0,8 |
| Spaulonci et al. (2013)(16) | -0,07 [-0,22, 0,09] | -0,09 [-0,70, 0,52] | -0,07 [-0,25, 0,12] | 94 (-118,81, 306,81) | – | 0,07 [-0,02, 0,15] | 0,07 [-0,09, 0,22] | 10 |
| Ruholamin et al. (2014)(17) | 0,02 [-0,07, 0,11] | – | -0,04 [-0,22, 0,14] | 166 (-19,5, 351,5) | 0,04 [-0,03, 0,11] | 0,00 [-0,04, 0,04] | 0,04 [-0,03, 0,11] | Apgar 7 - 1 Apgar 8 - 16 Apgar 9 - 33 |
| Ainuddin et al. (2015)(18) | 0,08 [0,01, 0,15] | 0,40 [-0,13, 0,93] | 0,09 [-0,10, 0,27] | 300 (135,38, 464,62) | 0,19 [0,03, 0,36] | 0,14 [-0,03, 0,22] | 0,17 [0,05, 0,28] | 8,6 ± 0,9 |
| Simeonova-Krstevska et al. (2018)(19) | -0,02 [-0,11, 0,07] | -1,40 [-1,98, -0,82] | 0,15 [-0,02, 0,32] | -148 (-346,02, 50,02) | – | 0,09 [-0,03, 0,22] | 0,16 [-0,01, 0,33] | 8,6 ± 0,7 |
| Ghomian et al. (2019)(20) | – | – | 0,06 [-0,05, 0,18] | 94 (3,70, 184,30) | -0,01 [-0,11, 0,08] | – | 0,03 [-0,03, 0,10] | Apgar <7 - 16 Apgar ≥ 7 - 127 |
| Picón-César et al. (2021)(8) | -0,01 [-0,04, 0,02] | 0,02 [-0,51, 0,55] | 0,25 [0,11, 0,38] | 62 (-94,40, 218,40) | 0,00 [-0,02, 0,02] | 0,05 [-0,06, 0,15] | 0,15 [0,06, 0,24] | 9,77 ± 0,55 |
RD: Risk difference; MD: Mean Difference; CI95%: Confidence Interval 95%;
1
Risk difference (CI95%);
2
Mean difference (CI95%);
3
Mean; ± standard deviation or number of neonates with each score